Vericel Cost Of Revenue vs Capex To Revenue Analysis

VCEL Stock

USD 47.83 0.05 0.10%

Vericel Corp financial indicator trend analysis is much more than just breaking down Vericel Corp Ord prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vericel Corp Ord is a good investment. Please check the relationship between Vericel Corp Cost Of Revenue and its Capex To Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

Cost Of Revenue vs Capex To Revenue

Cost Of Revenue vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vericel Corp Ord Cost Of Revenue account and Capex To Revenue. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Vericel Corp's Cost Of Revenue and Capex To Revenue is 0.41. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Vericel Corp Ord, assuming nothing else is changed. The correlation between historical values of Vericel Corp's Cost Of Revenue and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Vericel Corp Ord are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Cost Of Revenue i.e., Vericel Corp's Cost Of Revenue and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

0.41

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Vericel Corp Ord income statement and represents the costs associated with goods and services Vericel Corp provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from Vericel Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vericel Corp Ord current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

At this time, Vericel Corp's Selling General Administrative is quite stable compared to the past year. Enterprise Value is expected to rise to about 1.7 B this year, although the value of Tax Provision will most likely fall to about 331.1 K.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	113.9M	126.8M	142.0M	149.1M
Cost Of Revenue	50.2M	54.6M	61.9M	65.0M

Total Operating Expenses Cost Of Revenue

Vericel Corp fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock Total Equity	Short Term Investments	Common Stock	Inventory	Property Plant Equipment
Total Assets		0.94	0.53	0.94	0.99	0.97	0.23	-0.62	0.92	0.94	0.97	0.98	0.98	0.85	0.9	0.99	0.85	0.95	0.9	0.99	0.88	0.73	0.76	0.92	0.95	0.96
Short Long Term Debt Total	0.94		0.46	0.84	0.89	0.95	0.46	-0.36	0.84	0.89	0.94	0.89	0.9	0.75	0.98	0.94	0.8	0.97	0.87	0.9	0.83	0.58	0.69	0.77	0.86	0.9
Other Current Liab	0.53	0.46		0.75	0.5	0.56	-0.01	-0.25	0.7	0.51	0.54	0.5	0.49	0.24	0.43	0.56	0.84	0.55	0.65	0.5	0.42	0.57	0.37	0.44	0.43	0.41
Total Current Liabilities	0.94	0.84	0.75		0.91	0.93	0.15	-0.62	0.94	0.9	0.93	0.89	0.92	0.75	0.83	0.94	0.94	0.92	0.91	0.91	0.78	0.76	0.64	0.87	0.88	0.89
Total Stockholder Equity	0.99	0.89	0.5	0.91		0.93	0.14	-0.69	0.89	0.91	0.94	0.99	0.98	0.88	0.84	0.98	0.8	0.9	0.85	0.99	0.9	0.76	0.81	0.96	0.95	0.95
Property Plant And Equipment Net	0.97	0.95	0.56	0.93	0.93		0.31	-0.51	0.91	0.95	1.0	0.89	0.94	0.74	0.95	0.96	0.88	0.98	0.94	0.92	0.8	0.66	0.61	0.84	0.88	0.94
Net Debt	0.23	0.46	-0.01	0.15	0.14	0.31		0.35	0.08	0.08	0.31	0.14	0.2	0.11	0.51	0.23	0.22	0.41	0.15	0.16	0.27	-0.3	0.23	-0.01	0.21	0.32
Retained Earnings	-0.62	-0.36	-0.25	-0.62	-0.69	-0.51	0.35		-0.59	-0.55	-0.52	-0.64	-0.7	-0.79	-0.31	-0.62	-0.39	-0.42	-0.44	-0.66	-0.6	-0.64	-0.51	-0.86	-0.61	-0.58
Accounts Payable	0.92	0.84	0.7	0.94	0.89	0.91	0.08	-0.59		0.91	0.91	0.87	0.92	0.72	0.82	0.92	0.91	0.89	0.94	0.89	0.75	0.81	0.6	0.84	0.83	0.81
Cash	0.94	0.89	0.51	0.9	0.91	0.95	0.08	-0.55	0.91		0.95	0.89	0.91	0.74	0.9	0.93	0.84	0.93	0.94	0.91	0.71	0.77	0.54	0.84	0.89	0.89
Non Current Assets Total	0.97	0.94	0.54	0.93	0.94	1.0	0.31	-0.52	0.91	0.95		0.9	0.94	0.75	0.95	0.97	0.88	0.98	0.92	0.93	0.8	0.65	0.63	0.85	0.91	0.96
Cash And Short Term Investments	0.98	0.89	0.5	0.89	0.99	0.89	0.14	-0.64	0.87	0.89	0.9		0.96	0.88	0.82	0.97	0.78	0.88	0.83	1.0	0.91	0.76	0.86	0.94	0.94	0.92
Net Receivables	0.98	0.9	0.49	0.92	0.98	0.94	0.2	-0.7	0.92	0.91	0.94	0.96		0.9	0.87	0.98	0.8	0.92	0.87	0.98	0.89	0.76	0.76	0.95	0.94	0.93
Common Stock Shares Outstanding	0.85	0.75	0.24	0.75	0.88	0.74	0.11	-0.79	0.72	0.74	0.75	0.88	0.9		0.67	0.85	0.53	0.73	0.62	0.9	0.86	0.65	0.8	0.94	0.86	0.82
Non Current Liabilities Total	0.9	0.98	0.43	0.83	0.84	0.95	0.51	-0.31	0.82	0.9	0.95	0.82	0.87	0.67		0.9	0.82	0.98	0.87	0.85	0.72	0.53	0.55	0.71	0.85	0.9
Other Current Assets	0.99	0.94	0.56	0.94	0.98	0.96	0.23	-0.62	0.92	0.93	0.97	0.97	0.98	0.85	0.9		0.85	0.95	0.9	0.98	0.89	0.74	0.76	0.92	0.93	0.94
Other Stockholder Equity	0.85	0.8	0.84	0.94	0.8	0.88	0.22	-0.39	0.91	0.84	0.88	0.78	0.8	0.53	0.82	0.85		0.89	0.9	0.8	0.63	0.68	0.53	0.7	0.79	0.79
Total Liab	0.95	0.97	0.55	0.92	0.9	0.98	0.41	-0.42	0.89	0.93	0.98	0.88	0.92	0.73	0.98	0.95	0.89		0.92	0.9	0.77	0.63	0.61	0.79	0.89	0.93
Property Plant And Equipment Gross	0.9	0.87	0.65	0.91	0.85	0.94	0.15	-0.44	0.94	0.94	0.92	0.83	0.87	0.62	0.87	0.9	0.9	0.92		0.85	0.72	0.82	0.51	0.76	0.79	0.81
Total Current Assets	0.99	0.9	0.5	0.91	0.99	0.92	0.16	-0.66	0.89	0.91	0.93	1.0	0.98	0.9	0.85	0.98	0.8	0.9	0.85		0.91	0.77	0.83	0.95	0.96	0.93
Short Term Debt	0.88	0.83	0.42	0.78	0.9	0.8	0.27	-0.6	0.75	0.71	0.8	0.91	0.89	0.86	0.72	0.89	0.63	0.77	0.72	0.91		0.65	0.9	0.87	0.78	0.8
Common Stock Total Equity	0.73	0.58	0.57	0.76	0.76	0.66	-0.3	-0.64	0.81	0.77	0.65	0.76	0.76	0.65	0.53	0.74	0.68	0.63	0.82	0.77	0.65		0.54	0.77	0.69	0.58
Short Term Investments	0.76	0.69	0.37	0.64	0.81	0.61	0.23	-0.51	0.6	0.54	0.63	0.86	0.76	0.8	0.55	0.76	0.53	0.61	0.51	0.83	0.9	0.54		0.78	0.77	0.72
Common Stock	0.92	0.77	0.44	0.87	0.96	0.84	-0.01	-0.86	0.84	0.84	0.85	0.94	0.95	0.94	0.71	0.92	0.7	0.79	0.76	0.95	0.87	0.77	0.78		0.9	0.88
Inventory	0.95	0.86	0.43	0.88	0.95	0.88	0.21	-0.61	0.83	0.89	0.91	0.94	0.94	0.86	0.85	0.93	0.79	0.89	0.79	0.96	0.78	0.69	0.77	0.9		0.96
Property Plant Equipment	0.96	0.9	0.41	0.89	0.95	0.94	0.32	-0.58	0.81	0.89	0.96	0.92	0.93	0.82	0.9	0.94	0.79	0.93	0.81	0.93	0.8	0.58	0.72	0.88	0.96

Click cells to compare fundamentals

Vericel Corp Account Relationship Matchups

Vericel Corp fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	153.2M	205.6M	243.7M	273.0M	353.7M	371.3M
Other Current Liab	1.2M	7.7M	41K	16.2M	17.2M	18.1M
Total Current Liabilities	19.8M	22.5M	26.1M	37.5M	45.7M	48.0M
Total Stockholder Equity	111.1M	134.3M	170.5M	192.3M	226.0M	237.2M
Property Plant And Equipment Net	32.2M	57.7M	59.0M	57.4M	115.1M	120.9M
Net Debt	814K	19.6M	(18.2M)	(3.5M)	1.3M	1.3M
Retained Earnings	(378.7M)	(375.8M)	(383.3M)	(400.0M)	(403.2M)	(383.0M)
Accounts Payable	6.3M	6.8M	9.0M	16.9M	22.3M	23.5M
Cash	26.9M	33.6M	68.3M	51.1M	86.9M	91.2M
Non Current Assets Total	41.6M	82.0M	85.2M	86.1M	148.0M	155.4M
Cash And Short Term Investments	69.7M	75.8M	103.4M	119.5M	127.3M	133.7M
Net Receivables	32.2M	34.5M	37.4M	46.5M	58.4M	61.3M
Common Stock Shares Outstanding	44.2M	47.3M	46.5M	47.1M	47.6M	50.0M
Liabilities And Stockholders Equity	153.2M	205.6M	243.7M	273.0M	353.7M	371.3M
Non Current Liabilities Total	22.4M	48.9M	47.2M	43.3M	82.0M	86.1M
Other Current Assets	3.0M	3.9M	4.2M	4.8M	6.9M	7.2M
Other Stockholder Equity	21K	127.6M	177.9M	592.3M	681.1M	715.2M
Total Liab	42.1M	71.3M	73.2M	80.7M	127.7M	134.1M
Property Plant And Equipment Gross	32.2M	30K	59.0M	57.4M	137.3M	144.2M
Total Current Assets	111.7M	123.6M	158.5M	186.9M	205.6M	215.9M
Accumulated Other Comprehensive Income	21K	14K	(154K)	(978K)	(100K)	(105K)
Common Stock Total Equity	489.7M	6.6M	553.9M	593.2M	682.2M	716.3M
Short Term Investments	42.8M	42.2M	35.1M	68.5M	40.5M	42.5M
Common Stock	489.7M	510.1M	553.9M	593.2M	629.2M	660.7M
Inventory	6.8M	9.4M	13.4M	16.0M	13.1M	13.7M
Property Plant Equipment	32.2M	57.7M	59.0M	57.4M	66.0M	69.3M
Net Tangible Assets	111.1M	134.3M	170.5M	184.8M	212.5M	223.1M
Retained Earnings Total Equity	(378.7M)	(375.8M)	(383.3M)	(400.0M)	(360.0M)	(378.0M)
Non Currrent Assets Other	89K	211K	528K	1.3M	771K	732.5K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

LAAC	Lithium Americas Corp
F	Ford Motor
CHPT	ChargePoint Holdings

When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:

How To Invest In Vericel

Details

Is Vericel Stock a good investment?

Details

What is Vericel Corp's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

Note that the Vericel Corp Ord information on this page should be used as a complementary analysis to other Vericel Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Vericel Stock analysis

When running Vericel Corp's price analysis, check to measure Vericel Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vericel Corp is operating at the current time. Most of Vericel Corp's value examination focuses on studying past and present price action to predict the probability of Vericel Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vericel Corp's price. Additionally, you may evaluate how the addition of Vericel Corp to your portfolios can decrease your overall portfolio volatility.

	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Transaction History View history of all your transactions and understand their impact on performance
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals

Is Vericel Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.045

Earnings Share

(0.07)

Revenue Per Share

4.15

Quarterly Revenue Growth

0.233

Return On Assets

(0.01)

The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vericel Cost Of Revenue vs Capex To Revenue Analysis

Cost Of Revenue vs Capex To Revenue

Cost Of Revenue vs Capex To Revenue Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Capex To Revenue

Vericel Corp fundamental ratios Correlations

Vericel Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Vericel Corp fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Vericel Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.99	Total Assets
Other Current Assets	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity

Common Stock	- 0.86	Retained Earnings
Common Stock Shares Outstanding	- 0.79	Retained Earnings
Net Receivables	- 0.7	Retained Earnings
Retained Earnings	- 0.69	Total Stockholder Equity
Total Current Assets	- 0.66	Retained Earnings
Common Stock Total Equity	- 0.64	Retained Earnings